Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
शेयरों में रैंक
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
शेयर मूल्य
$6.17
मार्केट कैप
$3.52B
बदलाव (1 दिन)
-0.05%
बदलाव (1 वर्ष)
-1.86%
देश
CN
व्यापार Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
श्रेणी
Healthcare
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329) के लिए कमाई
2026 में कमाई TTM: 0
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान कमाई 0 है। 2026 में कंपनी ने 0 की कमाई की, जो 2026 की कमाई 0 के के बराबर है। इस पृष्ठ पर दिखाई गई कमाई ब्याज और कर से पहले की कमाई है, जिसे EBIT कहा जाता है।
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited के लिए कमाई का इतिहास 2001 से 2026 तक
प्रत्येक वर्ष के अंत में कमाई
| वर्ष | कमाई | परिवर्तन |
|---|---|---|
| 2025 | $355.53M | 0.63% |
| 2024 | $353.30M | 128.32% |
| 2023 | $154.74M | 8.90% |
| 2022 | $142.10M | 3.48% |
| 2021 | $137.32M | 16.80% |
| 2020 | $117.57M | 10.16% |
| 2019 | $106.72M | 14.59% |
| 2018 | $93.13M | 14.11% |
| 2017 | $81.61M | 21.49% |
| 2016 | $67.18M | -18.79% |
| 2015 | $82.72M | 18.91% |
| 2014 | $69.56M | 1.17% |
| 2013 | $68.76M | -17.14% |
| 2012 | $82.98M | 85.74% |
| 2011 | $44.67M | -16.41% |
| 2010 | $53.45M | 42.73% |
| 2009 | $37.45M | 56.81% |
| 2008 | $23.88M | -711.08% |
| 2007 | $-3.91M | -92.20% |
| 2006 | $-50.07M | -485.02% |
| 2005 | $13.00M | 15.50% |
| 2004 | $11.26M | -23.83% |
| 2003 | $14.78M | 20.06% |
| 2002 | $12.31M | 20.70% |
| 2001 | $10.20M | 0.00% |
समान कंपनियों या प्रतियोगियों की कमाई
| कंपनी | कमाई | कमाई में अंतर | देश |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
